Clinical Trials Sponsored by Beijing Chest Hospital

Total 3418 results

Beijing Chest Hospital

Not yet recruiting

Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer

Malnutrition | Lung Cancer | Amino Acid Deficiency
Beijing Chest Hospital

Recruiting

Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis

Tuberculosis

China
Beijing Chest Hospital

Unknown

Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

China
Beijing Chest Hospital

Not yet recruiting

A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC

Non-small Cell Lung Cancer
Beijing Chest Hospital

Recruiting

A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2

Tuberculosis, Pulmonary

China
Beijing Chest Hospital

Unknown

The Efficacy and Drug Resistance Molecular Biology of Apatinib Combined With EGFR-TK1 Treated for Advanced Slow-progressed Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

China
Beijing Chest Hospital

Unknown

Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration：A Real World Exploratory Study

NSCLC Stage IV | NSCLC Stage IIIB
Beijing Chest Hospital

Not yet recruiting

Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLC

Extensive-stage Small-cell Lung Cancer
Beijing Chest Hospital

Recruiting

A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China (PROSPECT)

Tuberculosis, Multidrug-Resistant

China
Beijing Chest Hospital

Recruiting

Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis

Tuberculous Meningitis

China
Beijing Chest Hospital

Completed

The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB

Multi-drug Resistant Tuberculosis

China
Beijing Chest Hospital

Active, not recruiting

Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China

Multidrug Resistant Tuberculosis

China
Beijing Chest Hospital

Unknown

Study on the Management Model of "Home Treatment" for Tuberculosis Patients

Tuberculosis, Pulmonary

China
Beijing Tongren Hospital
Beijing Chest Hospital

Recruiting

Using Thoracic Paravertebral Block for Perioperative Lung Preservation During VATS Pulmonary Surgery

Postoperative Pulmonary Complications

China
Beijing Chest Hospital
Shandong Chest Hospital; Zhengzhou Sixth People's Hospital

Active, not recruiting

Early Bactericidal Activity Safety Pulmonary Tuberculosis Pyrifazimine (TBI-166)

Sensitive Pulmonary Tuberculosis

China
Beijing Chest Hospital
Beijing Municipal Science & Technology Commission

Unknown

The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis

Tuberculosis, Spinal

China
Beijing Chest Hospital, Capital Medical University

Not yet recruiting

PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC (NeoSCLC-001)

Limited-stage Small-cell Lung Cancer
Geneplus-Beijing Co. Ltd.
Shanghai Chest Hospital

Completed

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China

Lung Neoplasms | Adenocarcinoma of Lung | Lung Cancer, Nonsmall Cell | Squamous Cell Lung Cancer

China
Geneplus-Beijing Co. Ltd.
Shanghai Chest Hospital

Recruiting

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

Lung Neoplasms | Adenocarcinoma of Lung | Lung Cancer, Nonsmall Cell | Squamous Cell Lung Cancer

China
Jinghui Wang

Recruiting

A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy.

Lung Cancer

China
Beijing Chest Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer

Small Cell Lung Cancer
Tianjin Chest Hospital
LinkDoc Technology (Beijing) Co. Ltd.

Completed

A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Beijing Chest Hospital
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer With Rare Mutations in HER2

HER2 Mutant Non-small Cell Lung Cancer
Chengdu CoenBiotech Co., Ltd
Beijing Friendship Hospital; Beijing Chest Hospital, Capital Medical University

Completed

Phase I Clinical Trial to Evaluate the Safety of Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) in Healthy Adults Aged 18-65 and Patients With Pulmonary Tuberculosis

Tuberculosis

China
Peking Union Medical College Hospital
Beijing Chao Yang Hospital; Beijing Hospital; Beijing Chest Hospital; China-Japan...

Unknown

Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC

Extensive-stage Small Cell Lung Cancer

China
Beijing Chest Hospital
National Medical Center for Infectious Diseases

Recruiting

Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort (INSPIRE-CODA)

Pulmonary Tuberculosis | Rifampicin-resistant Tuberculosis

China
Shanghai Chest Hospital

Recruiting

Prediction of Anastomotic Complications and Recurrent Laryngeal Nerve Injury Based on Postoperative Early Endoscopic Evaluation

Anastomotic Leak | Esophageal Neoplasm | Anastomotic Stenosis | Recurrent Laryngeal Nerve Injuries | Endoscopic Evaluation

China
Shanghai Chest Hospital

Not yet recruiting

Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective Phase 2 Clinical Trial

Esophageal Squamous Cell Carcinoma

China
Shanghai Chest Hospital

Not yet recruiting

RAE Versus MIE in Patients With Esophageal Cancer After Neoadjuvant Therapy

Surgical Procedure, Unspecified

China
Shanghai Chest Hospital

Recruiting

Molecular Analysis and Treatment Options of SCLC

Small Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Limited Stage | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer, Combined Type

China
Shanghai Chest Hospital

Recruiting

Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations

NSCLC | NSCLC Stage IV | NSCLC, Recurrent

China
Shanghai Chest Hospital

Recruiting

Molecular Analysis and Treatment Options of Thymic Malignancies

Thymic Carcinoma | Thymic Epithelial Tumor | Thymic Cancer

China
Tianjin Chest Hospital

Recruiting

Pembrolizumab as First-line Treatment for Advanced NSCLC Complicated With COPD

NSCLC With COPD

China
Shanghai Chest Hospital

Not yet recruiting

Salvage Immunotherapy and Chemotherapy in Esophageal Squamous Cell Carcinoma Patients Nonresponding to Initial Neoadjuvant Chemoradiotherapy (SINCERE)

Esophageal Squamous Cell Carcinomas
Shanghai Chest Hospital

Recruiting

ENB-guided Ablation Therapy Combined With VATS in the Treatment of MPLC

Lung Cancer

China
Tianjin Chest Hospital

Recruiting

CCTA Improves Clinical Management of Stable Chest Pain (CICM-SCP)

Coronary Artery Disease | Major Adverse Cardiovascular Events | Coronary Computed Tomography Angiography | Revascularization | Stable Chest Pain | Optimal Medical Therapy | Invasive Coronary Angiography

China
Shanghai Chest Hospital

Recruiting

China Lung Cancer Screening (CLUS) Study Version 2.0

Lung Neoplasms

China
Tianjin Chest Hospital

Recruiting

Intravascular Ultrasound-derived Assessment of Hemodynamically Negative Lesions in NSTEACS Patients (IMPACT-NSTEACS)

Non-ST-segment Acute Coronary Syndrome

China
Shanghai Chest Hospital

Active, not recruiting

To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.

Extensive-Stage Small-Cell Lung Cancer

China
Shanghai Chest Hospital

Completed

The Chinese Registration Study of Driver Ablation of Persistent Atrial Fibrillation.

Atrial Fibrillation, Persistent

China
Shanghai Chest Hospital

Unknown

To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

Radiotherapy | Non-small Cell Lung Cancer Stage IIIA

China
Shanghai Chest Hospital

Unknown

Prediction Model of Peripheral Pulmonary Lesions Based on R-EBUS Image (R-EBUS)

Diagnoses Disease

China
Shanghai Chest Hospital

Unknown

Transbronchial Ablation for Peripheral Lung Tumor

Lung Cancer

China
Shanghai Chest Hospital

Unknown

ENB Guided MWA for Early-stage Peripheral Lung Cancer

Lung Cancer

China
Shanghai Chest Hospital

Unknown

Clinical Study of ctDNA and Exosome Combined Detection to Identify Benign and Malignant Pulmonary Nodules (ctDNA)

Pulmonary Nodules

China
Shanghai Chest Hospital

Unknown

First-line Combination Treatment Based on Anlotinib

Lung Cancer | Advanced Stage

China
Shanghai Chest Hospital

Unknown

EBUS Image Features in the Diagnosis of PPLs

Endobronchial Ultrasound
Shanghai Chest Hospital

Completed

The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves Replacement

Right Heart Failure | Tricuspid Regurgitation

China
Shanghai Chest Hospital

Unknown

Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma

Pulmonary Large Cell Neuroendocrine Carcinoma
Shanghai Chest Hospital

Unknown

18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study

Non-small-cell Lung Cancer

3

Subscribe